Загрузка...

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion therapy has contributed to the understanding of B cells as major players in several autoimmune diseases. The first therapeutic anti-CD20 mAb, rituximab, is a murine–human chimera to which many patients develop anti...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Auto Immun Highlights
Главные авторы: Du, Fanny Huynh, Mills, Elizabeth A., Mao-Draayer, Yang
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688039/
https://ncbi.nlm.nih.gov/pubmed/29143151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13317-017-0100-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!